Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 96512
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.96512
Table 2 Intraoperative and postoperative characteristics of patients with high and low serum total bilirubin-albumin ratio, n (%)
Variable
Median (range)
High B/A group (> 0.87)
Low B/A group (≤ 0.87)
P value
Intraoperative data
Estimated blood loss (mL)403 (50-2000)420 (50-1500)397 (50-2000)0.792
Intraoperative transfusion (mL)446 (0-1400)637 (400-1400)381 (200-1200)< 0.001
Spleen volume (mm3)1291 (157-4896)1389 (270-3864)1256 (156-4896)0.278
Spleen size (mL)159 (12-230)168 (106-230)155 (12-224)0.063
Surgical methods
Laparoscopic surgery35 (13.62)6 (9.38)29 (15.03)0.253
Laparotomy222 (86.38)58 (90.63)164 (84.97)
Postoperative complications
ICU stay2 (0.78)1 (1.56)1 (0.52)0.437
Hemorrhage4 (1.56)3 (4.69)1 (0.52)0.049
Portal vein thrombosis45 (17.51)7 (10.94)38 (19.69)0.110
Ascites142 (55.25)47 (73.44)95 (49.22)0.001
Hepatic encephalopathy2 (0.78)1 (1.56)1 (0.52)0.437
Surgical site infection14 (5.45)6 (9.38)8 (4.15)0.110
Pneumonia7 (2.72)2 (3.13)5 (2.59)1.000
SIRS133 (51.75)30 (46.88)103 (53.37)0.368
CCI > 3077 (29.96)26 (40.63)51 (26.42)0.032
Length of hospital stay (d)27 (11-88)30 (14-88)26 (11-86)0.030
Survival time (months)64.6 (0.3-185.0)56.8 (0.3-166.8)67.2 (2.4-185.0)0.045
Survival (yes/no)221 (85.99)/36 (14.01)46 (71.88)/18 (28.12)175 (90.67)/18 (9.33)< 0.001
HCC occurrence (yes/no)40 (15.56)/217 (84.44)10 (15.63)/54 (84.37)30 (15.54)/163 (84.46)0.988